ATE110742T1 - Peptid-verbindungen. - Google Patents

Peptid-verbindungen.

Info

Publication number
ATE110742T1
ATE110742T1 AT89202310T AT89202310T ATE110742T1 AT E110742 T1 ATE110742 T1 AT E110742T1 AT 89202310 T AT89202310 T AT 89202310T AT 89202310 T AT89202310 T AT 89202310T AT E110742 T1 ATE110742 T1 AT E110742T1
Authority
AT
Austria
Prior art keywords
peptide compounds
derivatives
pentapeptides
termini
inhibition
Prior art date
Application number
AT89202310T
Other languages
English (en)
Inventor
Ole Didrik Laerum
Original Assignee
Hafslund Nycomed As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hafslund Nycomed As filed Critical Hafslund Nycomed As
Application granted granted Critical
Publication of ATE110742T1 publication Critical patent/ATE110742T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/067—Hemoregulatory peptides based on sequence Glp-Glu-Asp-Cys-Lys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT89202310T 1988-09-16 1989-09-13 Peptid-verbindungen. ATE110742T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888821785A GB8821785D0 (en) 1988-09-16 1988-09-16 Peptide compounds

Publications (1)

Publication Number Publication Date
ATE110742T1 true ATE110742T1 (de) 1994-09-15

Family

ID=10643722

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89202310T ATE110742T1 (de) 1988-09-16 1989-09-13 Peptid-verbindungen.

Country Status (22)

Country Link
US (1) US5484770A (de)
EP (2) EP0359338B1 (de)
JP (1) JPH04500666A (de)
KR (1) KR900701828A (de)
CN (1) CN1041159A (de)
AT (1) ATE110742T1 (de)
AU (1) AU641366B2 (de)
CA (1) CA1339947C (de)
DE (1) DE68917837T2 (de)
DK (1) DK39591A (de)
ES (1) ES2058479T3 (de)
GB (1) GB8821785D0 (de)
GE (1) GEP19971041B (de)
HU (2) HU895788D0 (de)
IE (1) IE64181B1 (de)
LT (1) LT3714B (de)
LV (1) LV10108B (de)
MY (1) MY104909A (de)
NZ (1) NZ230654A (de)
RU (1) RU2079509C1 (de)
WO (1) WO1990002753A1 (de)
ZA (1) ZA896980B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620957A (en) * 1989-07-14 1997-04-15 Smithkline Beecham Corporation Hemoregulatory peptides
HU206372B (en) * 1990-09-03 1992-10-28 Richter Gedeon Vegyeszet Process for producing new oligopeptides which selectively inhibit proliferation of haemopoietic cells and pharmaceutical compositions comprising same
HU206374B (en) * 1990-09-03 1992-10-28 Richter Gedeon Vegyeszet Process for producing pentapeptide and its salts specifically inhibiting proliferation of epidermic cells, as well as pharmaceutical compositions comprising same as active ingredient
TW222280B (de) * 1991-11-26 1994-04-11 Smithkline Beecham Corp
IL104323A0 (en) * 1992-01-10 1993-05-13 Smithkline Beecham Corp Hemoregulatory peptides
GB9211674D0 (en) 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
GB9211668D0 (en) * 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
GB9211677D0 (en) 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
GR1001502B (el) * 1992-11-26 1994-02-28 Smithkline Beecham Corp Αιμορυ?μιστικά πεπτίδια.
CN1034735C (zh) * 1993-01-02 1997-04-30 史密丝克莱恩比彻姆公司 血调节肽
US5521284A (en) * 1994-08-01 1996-05-28 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide amides and esters
US5504191A (en) * 1994-08-01 1996-04-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide methyl esters
EP1070727A1 (de) * 1999-03-01 2001-01-24 Aventis Pharma Deutschland GmbH Niedermolekulare Peptide als Inhibitoren der Laminin/Nidogen Wechselwirkung
CN1403474A (zh) * 2001-09-05 2003-03-19 中国人民解放军军事医学科学院生物工程研究所 一种短肽及以其为活性成份的药物
RU2373220C2 (ru) * 2002-07-23 2009-11-20 Сосьете Де Консей Де Решерш Э Д`Аппликасьон Сьентифик (С.К.Р.А.С.) Аналоги грелина

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA838780B (en) * 1982-11-26 1985-01-30 Nyegaard & Co As Peptide compounds
NO860752L (no) * 1985-06-26 1986-12-29 Bio Tech As Pentapeptider med cellevekstregulerende virkning og fremgangsmaate for fremstilling derav.
US4748154A (en) * 1985-12-24 1988-05-31 Takeda Chemical Industries, Ltd. Peptide derivatives, their production and use
GB8626539D0 (en) * 1986-11-06 1986-12-10 Nycomed As Peptide compounds

Also Published As

Publication number Publication date
KR900701828A (ko) 1990-12-04
HU208027B (en) 1993-07-28
IE892954L (en) 1990-03-16
RU2079509C1 (ru) 1997-05-20
CN1041159A (zh) 1990-04-11
GEP19971041B (en) 1997-11-26
DE68917837D1 (de) 1994-10-06
LT3714B (en) 1996-02-26
AU641366B2 (en) 1993-09-23
LV10108B (en) 1994-10-20
DK39591D0 (da) 1991-03-06
NZ230654A (en) 1991-10-25
LTIP610A (en) 1994-12-27
WO1990002753A1 (en) 1990-03-22
HU895788D0 (en) 1991-08-28
JPH04500666A (ja) 1992-02-06
ZA896980B (en) 1990-06-27
US5484770A (en) 1996-01-16
LV10108A (lv) 1994-05-10
EP0359338A1 (de) 1990-03-21
DE68917837T2 (de) 1994-12-22
ES2058479T3 (es) 1994-11-01
DK39591A (da) 1991-03-06
HUT58765A (en) 1992-03-30
EP0359338B1 (de) 1994-08-31
GB8821785D0 (en) 1988-10-19
CA1339947C (en) 1998-07-07
MY104909A (en) 1994-06-30
IE64181B1 (en) 1995-07-12
AU4218389A (en) 1990-04-02
EP0434718A1 (de) 1991-07-03

Similar Documents

Publication Publication Date Title
CA2270289A1 (en) Proteins with enhanced levels of essential amino acids
DE68917837D1 (de) Peptid-Verbindungen.
PT883687E (pt) Receptores de quimiocinas c-c, ckr-5, cc, os seus derivados e as suas utilizacoes
PT1288223E (pt) Derivados de peptidos terapeuticos
EP0182372A3 (de) Faktor-VIII-gerinnende Polypeptide
NO940299L (no) Peptid med organbeskyttende aktivitet
ATE144535T1 (de) Plättchen blockierende peptide
DE69715181D1 (de) Peptid der löslichen form von acetylcholinesterase mit aktivität als calciumkanalmodulator
EP0592566A4 (de) Cysteinfreie il-6 mutanten.
HUP9900506A2 (hu) Protrombinszármazékok
ATE41773T1 (de) 4,5-dihydro-4-oxo-2((2-transphenylcyclopropyl)amino>-3-furancarbonsaeuren und derivate davon.
ATE42308T1 (de) Pharmakologisch aktive peptide.
ATE124955T1 (de) Substrat-peptide.
DE59109235D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
DE69733026D1 (de) Cyclin e spezifische konstrukte und komplexe
DE68908958D1 (de) Peptide.
FR2654430B1 (fr) Nouveaux derives de peptides, utilisables comme inhibiteurs des collagenases bacteriennes.
ATE432985T1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
NO910981L (no) Peptidforbindelser.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee